肺癌胸科手术后慢性术后疼痛的10年单中心回顾性研究
该研究回顾性分析2007至2016年4218例肺癌胸科手术患者,最终纳入3200例,评估术后36个月内慢性术后疼痛(CPSP)的长期发生率。结果显示术后3个月和36个月CPSP发生率分别为14.3%和17.4%,且随时间下降,3.1%患者在术后至少6个月新发CPSP。女性、手术时间长、术后首次门诊11点数字评分法评分高、术后化疗和放疗是36个月内CPSP的显著预测因素。
要点
- 肺癌胸科手术后36个月CPSP发生率为17.4%,3个月为14.3%。
- CPSP发生率随时间下降,但3.1%患者在术后6个月后新发CPSP。
- 女性、手术时间长、术后高疼痛评分、化疗和放疗是CPSP预测因素。
核心结论
- 肺癌胸科手术后CPSP发生率随时间下降,但存在延迟发生或复发。
- 女性、手术时间长、术后首次门诊高疼痛评分、术后化疗和放疗是36个月内CPSP的显著预测因素。
研究设计与样本
- 单中心10年回顾性研究,回顾2007至2016年4218例连续肺癌胸科手术患者电子病历,最终纳入3200例分析。
主要发现
- 459例(14.3%)在术后3个月内诊断CPSP,558例(17.4%)在术后36个月内诊断CPSP。
- 99例(3.1%)在术后至少6个月新诊断CPSP。
- 女性(HR 1.20,95%CI 1.00至1.43;p=0.04)、手术时间较长(HR 1.11,95%CI 1.03至1.20;p<0.01)、术后首次门诊11点数字评分法评分较高(HR 1.29,95%CI 1.24至1.34;p<0.001)、术后化疗(HR 1.55,95%CI 1.26至1.90;p<0.001)、术后放疗(HR 1.35,95%CI 1.05至1.74;p=0.02)是36个月内CPSP的显著预测因素。
临床怎么用
- 对肺癌胸科手术患者应关注CPSP的长期发生,尤其是女性、手术时间长、术后疼痛评分高及接受化疗或放疗者。
- 术后首次门诊高疼痛评分可提示CPSP风险,需加强疼痛评估与随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The long-term incidence of chronic postsurgical pain (CPSP) after thoracic surgery has not yet been reported. METHODS: We retrospectively reviewed the electronic medical records of 4218 consecutive patients who underwent thoracic surgery for lung cancer between 2007 and 2016. We evaluated the long-term incidence of CPSP after thoracic surgery at intervals of 3 months for 36 months. A Cox proportional hazard regression analysis was performed to investigate the predictors of CPSP after thoracic surgery. RESULTS: A total of 3200 patients were included in the analysis. Of these, 459 (14.3%) and 558 (17.4%) patients were diagnosed with CPSP within 3 and 36 months after surgery, respectively. Furthermore, the incidence of CPSP decreased over time. Additionally, 99 (3.1%) patients were newly diagnosed with CPSP at least 6 months after surgery. Female sex (HR 1.20, 95% CI 1.00 to 1.43; p=0.04), longer duration of surgery (HR 1.11, 95% CI 1.03 to 1.20; p<0.01), higher 11-point Numeric Rating Scale score at first outpatient visit after surgery (HR 1.29, 95% CI 1.24 to 1.34; p<0.001), postoperative chemotherapy (HR 1.55, 95% CI 1.26 to 1.90; p<0.001), and postoperative radiation therapy (HR 1.35, 95% CI 1.05 to 1.74; p=0.02) were significant predictors of CPSP for 36 months after surgery. CONCLUSION: Our study showed a decreasing trend in the incidence of CPSP as well as delayed-onset or recurrent CPSP after thoracic surgery. A better understanding of the progression of CPSP after thoracic surgery may provide important information on its prediction and treatment.
引用
- Yoon S, Hong WP, Joo H, et al. Long-term incidence of chronic postsurgical pain after thoracic surgery for lung cancer: a 10-year single-center retrospective study. Reg Anesth Pain Med. 2020. PMID: 32188682. doi:10.1136/rapm-2020-101292
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。